⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 17, 2024Biomarkers in Medicine

Analyzing venous thromboembolism risk in malignant tumors: thromboelastogram and coagulation factors study

Wang Xue-Xing Jie Chu Chen Chunmei Yuan He Wei Chun-Mei

View Full Paper

Ask AI

Bookmark

Share

Abstract

This retrospective clinical study was designed to examine the predictive value of thromboelastography (TEG) combined with coagulation function for venous thromboembolism (VTE) in hospitalized patients with cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Xue-Xing et al. (2024) studied this question.

synapsesocial.com/papers/68e6ebd1b6db643587666725 https://doi.org/10.1080/17520363.2024.2342239

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Combined role of thromboelastography and coagulation indicators in predicting thromboembolism risk in cancer patients2025
2Assessing hypercoagulability and <scp>VTE</scp> risk using thromboelastography and Khorana score in women with cancers receiving chemotherapy2024 · 8 citations
3Using a thrombodynamics test for diagnostics of hypercoagulation and prediction of thromboembolic complications in patients with malignant tumors2024 · 2 citations
4Can Thromboelastography be Predictive of Venous Thromboembolism After Trauma: A Longitudinal, Prospective, Multi-Institution StudyCohort Study · 2025
5Prediction of venous thromboembolism in cancer patientscohort · 2010 · 782 citations